Peer-reviewedCC BYJournal for ImmunoTherapy of Cancer
951 Engineered tumor-homing bacteria enable systemic combination immune checkpoint blockade and cytokine immunotherapy
- 1Department of Neurosurgery & Brain and Nerve Research Laboratory, First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China
- 2University of Michigan, Ann Arbor, MI, USA
Related
- In situ-activated engineered bacteria release combined dual-therapeutic proteins for tumor immunotherapy
- Sense-and-respond: Engineered bacteria drive epithelial repair during gut inflammation
- 628 Vascular-metabolic checkpoint derives immunotherapy resistance in solid tumor
- Reversal of the neutrophil barrier for potentiating immune-engineered bacteria therapy in pancreatic cancer
- Targeted tumor desialylation by engineered probiotic reprograms the tumor microenvironment to potentiate immunotherapy
BibTeX
@article{wang2026engineered,
title = {{951 Engineered tumor-homing bacteria enable systemic combination immune checkpoint blockade and cytokine immunotherapy}},
author = {Zongqi Wang and Jiahe Li},
journal = {Journal for ImmunoTherapy of Cancer},
year = {2026},
month = nov,
doi = {10.1136/jitc-2026-sitc2026.0951},
url = {https://doi.org/10.1136/jitc-2026-sitc2026.0951},
note = {CC BY},
}
RIS
TY - JOUR
TI - 951 Engineered tumor-homing bacteria enable systemic combination immune checkpoint blockade and cytokine immunotherapy
AU - Zongqi Wang
AU - Jiahe Li
PY - 2026
DA - 2026/11/08
JO - Journal for ImmunoTherapy of Cancer
DO - 10.1136/jitc-2026-sitc2026.0951
UR - https://doi.org/10.1136/jitc-2026-sitc2026.0951
SN - 2051-1426
ER -